107 related articles for article (PubMed ID: 21427931)
1. [Possibility of correction of the lipid disorders in patients with cholelithiasis and gallbladder cholesterosis].
Ivanchenkova RA; Gatsenko VP; At'kova ER
Eksp Klin Gastroenterol; 2010; (9):81-9. PubMed ID: 21427931
[TBL] [Abstract][Full Text] [Related]
2. [Effect of ursodeoxycholic acid on the characteristics of lipid metabolism in cholelithiasis and gall-bladder cholesterosis].
Il'chenko AA; Drozhzhina IuV
Eksp Klin Gastroenterol; 2007; (5):29-34, 164. PubMed ID: 18389594
[TBL] [Abstract][Full Text] [Related]
3. [Influence of ursodeoxycholic acid on the immune status of patients with cholesterosis of gall-bladder depending on cholesterol index in blood].
Shcherbinina MB; Babets MI; Kudriavtseva VI
Eksp Klin Gastroenterol; 2014; (1):53-8. PubMed ID: 25518458
[TBL] [Abstract][Full Text] [Related]
4. [The treatment of gallbladder cholesterosis in children].
Kharitonova LA; Ermolenko NS
Eksp Klin Gastroenterol; 2014; (1):42-5. PubMed ID: 25518456
[TBL] [Abstract][Full Text] [Related]
5. [Cholesterosis of the gall bladder and atherogenic dyslipidemia: etiology, pathogenesis, clinical symptoms, diagnosis and treatment].
Lazebnik LB; Ovsiannikova ON; Zvenigorodskaia LA; Mel'nikova NV; Samsonova NG; Khomeriki SG
Ter Arkh; 2008; 80(1):57-61. PubMed ID: 18326230
[TBL] [Abstract][Full Text] [Related]
6. [Effectiveness of combined application of ursosan and anxiolytic 2-mercaptobenzimidazole in early stage of cholelithiasis].
Vakhrushev IaM; Khokhlacheva NA
Eksp Klin Gastroenterol; 2010; (4):105-8. PubMed ID: 20623958
[TBL] [Abstract][Full Text] [Related]
7. [Innovations in the diagnosis and treatment of cholelithiasis].
Ivanchenkova RA; Egorov AV; Leonovich AE; At'kova ER
Eksp Klin Gastroenterol; 2012; (4):66-73. PubMed ID: 23402157
[TBL] [Abstract][Full Text] [Related]
8. [Comparative evaluation of various methods of conservative therapy of early stage of cholelithiasis].
Vakhrushev IaM; Gorbunov AIu
Eksp Klin Gastroenterol; 2013; (6):7-10. PubMed ID: 24772852
[TBL] [Abstract][Full Text] [Related]
9. [Efficiency of ursotherapy in cholesterol-associated pathology of the gallbladder].
Il'chenko AA; Drozhzhina IuV
Eksp Klin Gastroenterol; 2009; (8):96-101. PubMed ID: 20469685
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of ursodeoxycholic acid in gallbladder cholesterosis accompanied by cholecystolithiasis].
Il'chenko AA; Orlova IuN
Eksp Klin Gastroenterol; 2003; (1):46-50, 182. PubMed ID: 12664784
[TBL] [Abstract][Full Text] [Related]
11. Gallstone disease: Microlithiasis and sludge.
Jüngst C; Kullak-Ublick GA; Jüngst D
Best Pract Res Clin Gastroenterol; 2006; 20(6):1053-62. PubMed ID: 17127187
[TBL] [Abstract][Full Text] [Related]
12. [Significance of biliary dysfunction in the pathogenesis of gallstone disease].
Il'chenko IA; Deliukina OV
Eksp Klin Gastroenterol; 2011; (7):70-8. PubMed ID: 22364003
[TBL] [Abstract][Full Text] [Related]
13. Neonatal cholelithiasis in Down syndrome: Is hypothyroidism involved? A case-report.
Ricci F; Stagi S; Messa F; de Martino M
J Neonatal Perinatal Med; 2018; 11(4):423-425. PubMed ID: 30149478
[TBL] [Abstract][Full Text] [Related]
14. [Gallbladder cholesterosis in patients with atherogenic dyslipidemia: pathogenesis, clinical picture, treatment].
Ovsiannikova ON; Zvenigorodskaia LA; Il'chenko AA
Eksp Klin Gastroenterol; 2008; (5):96-105. PubMed ID: 19148997
[No Abstract] [Full Text] [Related]
15. [Clinical and experimental study of danfukang granule in treating cholecystitis and cholelithiasis].
Niu SK; Wang JT; Li ZZ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1996 May; 16(5):277-9. PubMed ID: 9387718
[TBL] [Abstract][Full Text] [Related]
16. [Correction of functional and structural changes of the intestine by ursosan in patients with absence of the gall-bladder].
Kozlova IV; Volkov SV
Eksp Klin Gastroenterol; 2007; (4):66-72. PubMed ID: 18409493
[No Abstract] [Full Text] [Related]
17. [Biliary calculosis, cholesterosis of the gallbladder, xanthogranulematous cholecystitis: clinical-morphological parallels].
Shcherbinina MB; Zakrevskaia EV
Ter Arkh; 2008; 80(2):66-71. PubMed ID: 18372600
[TBL] [Abstract][Full Text] [Related]
18. [Condition of the intestinal tract microbiocenosis in patients with nonalcoholic fatty liver disease and the methods of its correction].
Kuchmin AN; Rezvan VV; Evsiukov KB; Fomin AA; Karshieva AV; Butikov VP
Voen Med Zh; 2010 Jun; 331(6):20-6. PubMed ID: 20731092
[TBL] [Abstract][Full Text] [Related]
19. Effects of long-term ursodeoxycholate administration on expression levels of secretory low-molecular-weight phospholipases A2 and mucin genes in gallbladders and biliary composition in patients with multiple cholesterol stones.
Kano M; Shoda J; Irimura T; Ueda T; Iwasaki R; Urasaki T; Kawauchi Y; Asano T; Matsuzaki Y; Tanaka N
Hepatology; 1998 Aug; 28(2):302-13. PubMed ID: 9695991
[TBL] [Abstract][Full Text] [Related]
20. [Effect of praziquantel and ursodeoxycholic acid therapy on bile lithogenicity in patients with opisthorchosis on the background of main variant of standard diet].
Korkin AL
Vopr Pitan; 2009; 78(2):63-6. PubMed ID: 19514346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
